Related Experiment Video
Updated: Sep 11, 2025
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC
Marie-Michelle McNicoll1, Alex M Mlynarek2, Keith Richardson2
1Undergraduate Medical Education, McGill University, Montréal, Quebec, Canada.
Background:
HPV-negative head and neck squamous cell carcinoma (HNSCC) patients can face prolonged gastrostomy tube (g-tube) dependence, affecting quality of life and delaying treatment. Existing models lack key health metrics like sarcopenia; this study develops a risk model to enhance preoperative assessment.
Methods:
This study analyzed 265 HNSCC patients. Sarcopenia was assessed via cervical paraspinal skeletal muscle mass (C3) on CT scans. Patients requiring g-tube support > 28 days were identified. Risk models were developed and compared to the PEG Score. A 50-patient validation cohort assessed model performance.
Results:
Key predictors included male sex, sarcopenia, prior radiotherapy, and adjuvant therapy. Logistic regression (LR) model had the highest AUC (0.78); followed by Recursive Partitioning analysis (RPA) model (0.76), both outperforming the PEG Score (0.67). RPA model maintained superior accuracy in validation (AUC = 0.79).
Conclusion:
RPA model outperformed PEG Score, offering a more precise risk tool for preoperative planning and early intervention.
